Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Phillips

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Methods in Molecular Medicine|September 18, 2004
Antisense inhibition: oligonucleotides, ribozymes, and siRNAsY Clare Zhang, Meghan M Taylor, Willis K Samson, et al.
Nature Reviews. Drug Discovery|January 1, 2010
Orphan products: an emerging trend in drug approvalsTimothy Coté, Aditya Kelkar, Kui Xu, et al.
Methods (San Diego, Calif.)|November 5, 2002
Vigilant vectors: adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-threatening diseasesYi Tang, Kai Schmitt-Ott, Keping Qian, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|April 3, 2024
Age Impacts Speech-in-Noise Recognition Differently for Nonnative and Native ListenersIan Phillips, Rebecca E Bieber, Coral Dirks, et al.
Current Pharmaceutical Design|August 4, 2015
Antisense Therapy for Cardiovascular DiseasesM Ian Phillips, Jessica Costales, Robert J Lee, et al.
Journal of the American Veterinary Medical Association|November 14, 2025
Owner compliance with radiographic follow-up after fracture stabilization in dogs and cats is influenced by distance, patient age, and invoiceAnne Pankowski, William Michael Karlin, Rich Evans, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 12, 2025
In Suspected Fetal Growth Restriction, sFlt-1/PlGF and PlGF May Have Value in Risk Stratification for Preterm Birth and Birthweight < 3rd Centile: A Blinded Cohort StudyRuth C E Hughes, Pippa Kyle, Ian Phillips, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 31, 2005
A vigilant, hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivoYao Liang Tang, Keping Qian, Y Clare Zhang, et al.
Regulatory Peptides|December 8, 2004
Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha (SDF-1alpha) treatmentYao Liang Tang, Keping Qian, Y Clare Zhang, et al.
Hypertension (Dallas, Tex. : 1979)|January 5, 2012
Exercise training prevents the microvascular rarefaction in hypertension balancing angiogenic and apoptotic factors: role of microRNAs-16, -21, and -126Tiago Fernandes, Flávio C Magalhães, Fernanda R Roque, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Methods in Molecular Medicine|September 18, 2004
Antisense inhibition: oligonucleotides, ribozymes, and siRNAsY Clare Zhang, Meghan M Taylor, Willis K Samson, et al.
Nature Reviews. Drug Discovery|January 1, 2010
Orphan products: an emerging trend in drug approvalsTimothy Coté, Aditya Kelkar, Kui Xu, et al.
Methods (San Diego, Calif.)|November 5, 2002
Vigilant vectors: adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-threatening diseasesYi Tang, Kai Schmitt-Ott, Keping Qian, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|April 3, 2024
Age Impacts Speech-in-Noise Recognition Differently for Nonnative and Native ListenersIan Phillips, Rebecca E Bieber, Coral Dirks, et al.
Current Pharmaceutical Design|August 4, 2015
Antisense Therapy for Cardiovascular DiseasesM Ian Phillips, Jessica Costales, Robert J Lee, et al.
Journal of the American Veterinary Medical Association|November 14, 2025
Owner compliance with radiographic follow-up after fracture stabilization in dogs and cats is influenced by distance, patient age, and invoiceAnne Pankowski, William Michael Karlin, Rich Evans, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 12, 2025
In Suspected Fetal Growth Restriction, sFlt-1/PlGF and PlGF May Have Value in Risk Stratification for Preterm Birth and Birthweight < 3rd Centile: A Blinded Cohort StudyRuth C E Hughes, Pippa Kyle, Ian Phillips, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 31, 2005
A vigilant, hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivoYao Liang Tang, Keping Qian, Y Clare Zhang, et al.
Regulatory Peptides|December 8, 2004
Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha (SDF-1alpha) treatmentYao Liang Tang, Keping Qian, Y Clare Zhang, et al.
Hypertension (Dallas, Tex. : 1979)|January 5, 2012
Exercise training prevents the microvascular rarefaction in hypertension balancing angiogenic and apoptotic factors: role of microRNAs-16, -21, and -126Tiago Fernandes, Flávio C Magalhães, Fernanda R Roque, et al.
Pageof 13